iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study.
Sugimoto N, Kanda J, Nakamura S, Kitano T, Hishizawa M, Kondo T, Shimizu S, Shigemasa A, Hirai H, Arai Y, Minami M, Tada H, Momose D, Koh KR, Nogawa M, Watanabe N, Okamoto S, Handa M, Sawaguchi A, Matsuyama N, Tanaka M, Hayashi T, Fuchizaki A, Tani Y, Takaori-Kondo A, Eto K.
Sugimoto N, et al. Among authors: nogawa m.
Blood. 2022 Dec 1;140(22):2398-2402. doi: 10.1182/blood.2022017296.
Blood. 2022.
PMID: 36112961
Free article.
Clinical Trial.
No abstract available.